Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1981 Jun 6;282(6279):1821–1822. doi: 10.1136/bmj.282.6279.1821

Recurrent herpes simplex: the outlook for systemic antiviral agents.

H J Field, P Wildy
PMCID: PMC1506437  PMID: 6263400

Full text

PDF
1821

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baringer J. R., Swoveland P. Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med. 1973 Mar 29;288(13):648–650. doi: 10.1056/NEJM197303292881303. [DOI] [PubMed] [Google Scholar]
  2. Bastian F. O., Rabson A. S., Yee C. L., Tralka T. S. Herpesvirus hominis: isolation from human trigeminal ganglion. Science. 1972 Oct 20;178(4058):306–307. doi: 10.1126/science.178.4058.306. [DOI] [PubMed] [Google Scholar]
  3. Blyth W. A., Harbour D. A., Hill T. J. Effect of acyclovir on recurrence of herpes simplex skin lesions in mice. J Gen Virol. 1980 Jun;48(Pt 2):417–419. doi: 10.1099/0022-1317-48-2-417. [DOI] [PubMed] [Google Scholar]
  4. Cabrera C. V., Wohlenberg C., Openshaw H., Rey-Mendez M., Puga A., Notkins A. L. Herpes simplex virus DNA sequences in the CNS of latently infected mice. Nature. 1980 Nov 20;288(5788):288–290. doi: 10.1038/288288a0. [DOI] [PubMed] [Google Scholar]
  5. De Clercq E., Descamps J., De Somer P., Barr P. J., Jones A. S., Walker R. T. (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2947–2951. doi: 10.1073/pnas.76.6.2947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Field H. J., Bell S. E., Elion G. B., Nash A. A., Wildy P. Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother. 1979 Apr;15(4):554–561. doi: 10.1128/aac.15.4.554. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fong B. S., Scriba M. Use of [125I]deoxycytidine to detect herpes simplex virus-specific thymidine kinase in tissues of latently infected guinea pigs. J Virol. 1980 Jun;34(3):644–649. doi: 10.1128/jvi.34.3.644-649.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Furman P. A., St Clair M. H., Fyfe J. A., Rideout J. L., Keller P. M., Elion G. B. Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate. J Virol. 1979 Oct;32(1):72–77. doi: 10.1128/jvi.32.1.72-77.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fyfe J. A., Keller P. M., Furman P. A., Miller R. L., Elion G. B. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J Biol Chem. 1978 Dec 25;253(24):8721–8727. [PubMed] [Google Scholar]
  11. Hirsch M. S., Swartz M. N. Drug therapy: antiviral agents (first of two parts). N Engl J Med. 1980 Apr 17;302(16):903–907. doi: 10.1056/NEJM198004173021607. [DOI] [PubMed] [Google Scholar]
  12. Kaufman H. E., Varnell E. D., Centifanto Y. M., Rheinstrom S. D. Effect of 9-(2-hydroxyethoxymethyl)guanine on herpesvirus-induced keratitis and iritis in rabbits. Antimicrob Agents Chemother. 1978 Dec;14(6):842–845. doi: 10.1128/aac.14.6.842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Klein R. J., Friedman-Kien A. E., DeStefano E. Latent herpes simplex virus infections in sensory ganglia of hairless mice prevented by acycloguanosine. Antimicrob Agents Chemother. 1979 May;15(5):723–729. doi: 10.1128/aac.15.5.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Maudgal P. C., De Clercq E., Descamps J., Missotten L., De Somer P., Busson R., Vanderhaeghe H., Verhelst G., Walker R. T., Jones A. S. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis. Antimicrob Agents Chemother. 1980 Jan;17(1):8–12. doi: 10.1128/aac.17.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Park N. H., Pavan-Langston D., McLean S. L. Acylovir in oral and ganglionic herpes simplex virus infections. J Infect Dis. 1979 Nov;140(5):802–806. doi: 10.1093/infdis/140.5.802. [DOI] [PubMed] [Google Scholar]
  16. Pavan-Langston D., Park N. H., Lass J. H. Herpetic ganglionic latency. Aciclovir and vidarabine therapy. Arch Ophthalmol. 1979 Aug;97(8):1508–1510. doi: 10.1001/archopht.1979.01020020170017. [DOI] [PubMed] [Google Scholar]
  17. Puga A., Rosenthal J. D., Openshaw H., Notkins A. L. Herpes simplex virus DNA and mRNA sequences in acutely and chronically infected trigeminal ganglia of mice. Virology. 1978 Aug;89(1):102–111. doi: 10.1016/0042-6822(78)90044-2. [DOI] [PubMed] [Google Scholar]
  18. Schaeffer H. J., Beauchamp L., de Miranda P., Elion G. B., Bauer D. J., Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978 Apr 13;272(5654):583–585. doi: 10.1038/272583a0. [DOI] [PubMed] [Google Scholar]
  19. Stevens J. G. Latent herpes simplex virus and the nervous system,. Curr Top Microbiol Immunol. 1975;70:31–50. doi: 10.1007/978-3-642-66101-3_2. [DOI] [PubMed] [Google Scholar]
  20. Wheeler C. E., Jr Pathogenesis of recurrent herpes simplex infections. J Invest Dermatol. 1975 Oct;65(4):341–346. doi: 10.1111/1523-1747.ep12607603. [DOI] [PubMed] [Google Scholar]
  21. Yamamoto H., Walz M. A., Notkins A. L. Viral-specific thymidine kinase in sensory ganglia of mice infected with herpes simplex virus. Virology. 1977 Feb;76(2):866–869. doi: 10.1016/0042-6822(77)90267-7. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES